2021 NLCRT Annual Meeting

2021 Annual Meeting Title

Date: December 6-7, 2021

Disparities to Equity: Moving the  Needle on Lung Cancer

Each year, the NLCRT membership, a nationwide coalition of over 160 professional and national societies, cancer centers, government agencies, research groups, advocacy and policy organizations, and corporate associates convenes to work together on our shared goal to create lung cancer survivors.

We thank all of NLCRT organizational members and non-members along with advocates, survivors, and caregivers for attending the 5th Annual Meeting.

Not currently a member? Learn more about NLCRT membership.

Day 1 Keynote Speaker

Monica Webb Hooper, PhD

Deputy Director of the National Institute on Minority Health and Health Disparities, National Institutes of Health

Monica Webb Hooper, PhD, is a leader in minority health and cancer-related health disparities research. Her work spans multiple disparity populations, including African Americans, Hispanics/Latinos, persons of lower socioeconomic privilege, and people living with HIV/AIDS.

dr monica hooper photo

Day 2 Keynote Speaker

Robert A Winn, MD

Director and Lipman Chair in Oncology
VCU Massey Cancer Center

Robert A. Winn, MD, is the director of the VCU Massey Cancer Center, a cancer center designated by the National Cancer Institute that provides advanced cancer care, conducts groundbreaking research to discover new therapies for cancer, offers high-quality education and training, and engages with the community to make advancements in cancer treatment and prevention equally available to all.

dr robert winn photo

2020 NLCRT Annual Meeting

2020 Welcome and Keynote

Date: December 7-8, 2020

NLCRT Theme: Forging the New Frontier of Lung Cancer

Each year, the NLCRT membership, a nationwide coalition of over 140 professional and national societies, cancer centers, government agencies, research groups, advocacy and policy organizations, and corporate associates convenes to work together on our shared goal to create lung cancer survivors.

We thank all of NLCRT organizational members and non-members along with advocates, survivors and caregivers for attending the 4th Annual Meeting.

Download the Attendee Meeting Program  2020 NLCRT Annual Meeting.

Not currently a member? Learn more about NLCRT membership.

Download the 2020 NLCRT Annual Meeting Executive Summary below for a comprehensive review.

Featured Speaker

Harry de Koning, MD, PhD

Dept. of Public Health, Erasmus MC University Medical Center Rotterdam, the Netherlands

Henricus J de Koning is currently serving as Deputy Head and Professor of Public Health & Screening Evaluation, Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.

Koning scientific contributions are in the areas of (1) designing, running and evaluating (often large-scale) multidisciplinary population-based randomized controlled screening trials to establish the efficacy of screening, (2) evaluating active (inter-)national screening programs and clinical tests to establish the effectiveness and (3) guiding public health policies on screening and primary prevention using predictions of favourable and unfavourable effects and the cost of interventions, based on micro-simulation modelling of the natural history of the disease, risk-prediction modelling and cost-effectiveness and cost-utility analyses. Our multidisciplinary and international research results in recommendations on whether or not to introduce screening, surveillance or other preventive interventions for specific diseases and on policy decisions to introduce it in specific ways, either at the population level or in (high risk) patients.

Agenda

Session Descriptions & Recordings

WELCOME TO THE NLCRT ANNUAL MEETING AND OPENING SESSION

Welcome and Opening Remarks
Ella Kazerooni, MD, MS, NLCRT Chair, University of Michigan

10:05am ET

Patient Story
Millicent Wilson, American Lung Association

Keynote Address
Harry de Koning, MD, PhD, Erasmus Medical Center, Rotterdam, the Netherlands

10:50am ET – 1:00pm ET

SESSION TWO: APPRAISING LUNG CANCER ACROSS THE CARE CONTINUUM

Lung Cancer Screening

Moderator: Peter Mazzone, MD, MPH, Cleveland Clinic

  • COVID-19: Screening and Lung Nodule Management Guidelines: Peter Mazzone, MD, MPH, Cleveland Clinic
  • Department of Veterans Affairs & GO2  Foundation for Lung Cancer Collaboration: Anita McGlothlin, GO2 Foundation for Lung Cancer
  • COVID-19: Screening and Lung Nodule Management Guidelines: Peter Mazzone, MD, MPH, Cleveland Clinic
  • First Million Screens in the American College of Radiology Lung Cancer Screening Registry: Gerard Silvestri, MD, MS, Medical University of South Carolina
  • USPSTF Lung Cancer Screening Guidelines Update: Ella Kazerooni, MD, MS, University of Michigan

Tobacco Treatment

Moderator: Jamie Ostroff, PhD, Memorial Sloan Kettering Cancer Center

  • NCI Smoking Cessation at Lung Examination (SCALE) Collaboration: Stephanie Land, PhD, National Cancer Institute
  • NCI Cancer Center Cessation Initiative (C3I): Graham Warren, MD, PhD, Medical University of South Carolina
  • Surgeon General Report on Smoking Cessation: Brenna VanFrank, MD, MSPH, Centers for Disease Control and Prevention

Surgical, Radiation and Medical Oncology

Moderator: Bruce Johnson, MD, Dana-Farber Cancer Institute

  • Enforcing the Need for State-of-the-Art Surgical Interventions: Brendon Stiles, MD, Weill Cornell Medicine
  • Stereotactic Radiotherapy Advancements: Anurag Singh, MD, Roswell Park Comprehensive Cancer Center
  • Targeted Therapy Advancements: Raymond Osarogiagbon, MBBS, Baptist Cancer Center, Memphis
  • COVID-19 in Patients with Lung Cancer: Gregory Riely, MD, PhD, Memorial Sloan Kettering Cancer Center

Disparities, Survivorship, Policy and Practice in Lung Cancer Care

Moderator: M. Patricia Rivera, MD, University North Carolina at Chapel Hill

  • Addressing Disparities in Lung Cancer Screening and Access: Louise Henderson, PhD, University of North Carolina at Chapel Hill
  • Fitness, Depression & Survivorship + COVID-19 in Lung Cancer Care: Brett Bade, MD, Yale University
  • HEDIS Measure & Telehealth Related to Screening and Access:  Ruth Carlos, MD, MS, University of Michigan
  • Improving Access to Biomarker Testing: Devon Adams, RN, MPH, ACS CAN

1:25pm ET – 2:15pm ET

SESSION THREE: POSTER SESSION

The poster session features 16 pre-recorded presentations that highlight lung cancer projects across the continuum of care. The moderated Question & Answer session will begin at 2:00pm ET.

Moderator: Jill Feldman, EGFR Resisters

2:15pm

Break

2:35pm ET – 4:40pm ET

SESSION FOUR: TASK GROUP SHOWCASES

Co-Moderators:
Joelle Fathi, DNP, ARNP, University of Washington
Jamie Studts, PhD, University of Colorado

Provider Engagement and Outreach Task Group
Chair: Thomas Houston, MD, American Academy of Family Physicians
Vice-Chair: Jan Eberth, PhD, University of South Carolina 

Additional Speakers:
Jennifer Lewis, MD, MS, MPH, Vanderbilt University
Efren Flores, MD, Massachusetts General Hospital
Robert Smith, PhD, American Cancer Society
Celeste Worth, MCHES, LuCa National Training Network, University of Louisville

Shared Decision-Making Task Group
Chair: Robert Volk, PhD, MD Anderson Cancer Center
Vice Chair: Peter Mazzone, MD,MPH Cleveland Clinic

Additional Presenter:
Ronald Myers, DSW, PhD, Thomas Jefferson University

Lung Cancer Screening Implementation Strategies Task Group
Chair: Charles White, MD, University of Maryland
Vice Chair: Carey Thomson, MD,MPH  Mt. Auburn/Beth Israel Lahey Health

Additional Presenters:
Debra Dyer, MD, National Jewish Hospital
Joelle Fathi, DNP, ARNP, University of Washington
Peter Mazzone, MD, MPH, Cleveland  Clinic

Tobacco Treatment in the Context of Lung Cancer Screening Task Group
Chair: Jamie Ostroff, PhD, Memorial Sloan Kettering Cancer Center
Vice Chair: Joelle Fathi,DNP, ARNP, University of Washington

4:40pm ET- 4:45pm ET

CLOSING REMARKS AND END OF DAY 1

Ella Kazerooni, MD, MS, NLCRT Chair, University of Michigan

2:30pm ET

Session Descriptions & Recordings

10:00am ET – 10:40am ET

WELCOME TO DAY 2 OF THE NLCRT ANNUAL MEETING

Welcome and Opening Remarks
Douglas Wood, MD, NLCRT Vice Chair, University of Washington

10:05am ET

Patient Story

Gina Kenney, Patient Advocate

National Estimates of Access to and Utilization of Lung Cancer Screening

  • Using Geospatial Analysis to Evaluate Access to Lung Cancer Screening in the United States: Liora Sahar, PhD, GISP, American Cancer Society
  • State Variation in Low-Dose CT Scanning for Lung Cancer Screening in the United States: Stacey Fedewa, PhD, MPH,  American Cancer Society

10:45am ET – 1:05 pm ET

SESSION SIX: NLCRT PRIORITY INITIATIVES AND SPECIAL PROJECTS

NLCRT Highlight: Summits & Initiatives
Moderator: Gerard Silvestri, MD, MS, Medical University of South Carolina

  • NLCRT Strategic Plan: Robert Smith, PhD, NLCRT PI, American Cancer Society
  • Eliminating Lung Cancer Stigma: A National Initiative
    • Advocate Perspective – Dusty Donaldson, Dusty Joy Foundation, LungCAN
    • Summit and Initiative Overview – Lisa Carter-Harris, PhD, APRN, ANP-C, Memorial Sloan Kettering Cancer Center
    • Advocate Perspective – Dusty Donaldson, Dusty Joy Foundation, LungCAN
    • Stigma Initiative Strategic Plan – Jamie Studts, PhD, University of Colorado
  • Optimizing Lung Cancer Biomarkers in Practice: A National Initiative
    • Advocate Perspective– Gina Hollenbeck, RN, BSN, ALK Positive
    • Summit and Initiative Overview – M. Patricia Rivera, MD, University of North Carolina at Chapel Hill
    • Stakeholder Confessions on Barriers to Comprehensive Biomarker Testing – Farhood Farjah, MD, MPH, University of Washington
    • Biomarker Initiative Strategic Plan – Bruce Johnson, MD, Dana-Farber Cancer Institute

NLCRT Highlight: Priority Projects
Moderator: Richard Wender, MD, Penn Medicine

  • State Lung Cancer Coalition-Building Guide: Jessica Olson, PhD, Medical College of Wisconsin
  • High Quality Lung Cancer Screening and Nodule Surveillance Programs – Modeling for Implementation and Programmatic Expansion: Carey Thomson, MD, MPH, Mt. Auburn/Beth Israel Lahey Health
  • Partnership with American Academy of Family Physicians – Shared Decision-Making Tools: Robert Volk, PhD, MD Anderson Cancer Center
  • American Cancer Society Regional Cancer Control Update: Letitia Thompson, MPA, American Cancer Society

SESSION SEVEN: ADVOCACY/HEALTH PLAN/INDUSTRY PANEL

Representatives from Industry, Payer, and Advocacy organizations will discuss the challenges they regard as most important to ensure that biomarker testing for patients with advanced NSCLC becomes routine, efficient, and high quality, and ways in which their organizations can contribute to a national collective initiative to advance biomarker testing and ensure patients receive state of the art care.

Moderator: Robert Smith, PhD, American Cancer Society

Speakers:
Jennifer Norton, Amgen
Katy Miller, AstraZeneca
Bryan Loy, MD, MBA, Humana
Jill Feldman, EGFR Resisters
Upal Basu Roy, PhD, MPH,  LUNGevity Foundation

2:30pm – 4:35pm ET

SESSION EIGHT: TASK GROUP SHOWCASE

Co-Moderators:
Jane Kim, MD, MPH, Department of Veterans Affairs
Douglas Wood, MD, University of Washington

Lung Cancer in Women Task Group
Chair: Leah Backhus, MD, MPH, Stanford University
Vice Chair: M. Patricia Rivera, MD, University of North Carolina at Chapel Hill

Additional Speaker:
Kim Sandler, MD, Vanderbilt University

State-Based Initiatives
Chair: Jessica Olson, PhD, Medical College of Wisconsin
Vice Chair: Timothy Mullett, MD, MBA, University of Kentucky

Additional Speakers:
Katie Bathje, American Cancer Society
Amy Copeland, MPH, Consultant, State-Based Initiatives Task Group

Advanced Imaging Task Group
Chair: Daniel Sullivan, MD, Duke University
Vice Chair: Michael McNitt-Gray, PhD, University of California, Los Angeles

Policy Action Task Group
Chair: Ruth Carlos, MD,MS, University of Michigan

Additional Speakers:
Andrea Borondy Kitts, MS, MPH, Rescue Lung Rescue Life
Sarah Downer, JD, Center for Health Law and Policy Innovation, Harvard

4:35 pm ET – 4:45 pm ET

CLOSING REMARKS AND END OF ANNUAL MEETING

Ella Kazerooni, MD, MS, NLCRT Chair, University of Michigan
Douglas Wood, MD, NLCRT Vice Chair, University of Washington

2019 NLCRT Annual Meeting

Date: December 9-10, 2019

Location: Capital Hilton, Washington DC

Each year, the NLCRT membership, a nationwide coalition of over 100 professional and national societies, cancer centers, government agencies, research groups, advocacy and policy organizations, and corporate associates convenes to work together on our shared goal to create lung cancer survivors.

The 2019 NLCRT Annual Meeting will feature presentations by nationally known experts, thought-leaders, and decision-makers on lung cancer and will facilitate national lung cancer awareness, prevention, early detection, and optimal diagnosis and therapy through public education, provider education, health policy activities, and the collective engagement of member organizations.

We need your critical thinking, expertise, and participation to advance our shared efforts.

Not currently a member? Learn more about NLCRT membership.

Featured Speaker

Susan Dentzer

Visiting Fellow

Robert J. Margolis Center for Health Policy Duke University

Susan Dentzer is one of the nation’s most respected health and health policy thought leaders and a frequent speaker and commentator on television and radio, including PBS and NPR, and an author of commentaries in Modern Healthcare, the New England Journal of Medicine and other prominent publications. She is currently a Senior Policy Fellow at the Duke-Margolis Center for Health Policy, the Washington, DC-based arm of Duke that focuses on health system transformation, biopharmaceutical policy, and other key health policy issues. She is also the editor and lead author of the book Health Care Without Walls: A Roadmap for Reinventing U.S. Health Care.

Dentzer previously served as President and Chief Executive Officer of NEHI, the Network for Excellence in Health Innovation; was senior policy adviser to the Robert Wood Johnson Foundation; editor-in-chief of the journal Health Affairs; and on-air Health Correspondent for the PBS NewsHour. She is an elected member of the National Academy of Medicine and the Council on Foreign Relations and is a fellow of the National Academy of Social Insurance and the Hastings Center. She is a member of the Board of Directors of the International Rescue Committee; Research!America; and the Public Health Institute. She also serves on the RAND Health Board of Advisors and the global public policy advisory committee for Roche.

Dentzer graduated from Dartmouth, is a trustee emerita of the college, and chaired the Dartmouth Board of Trustees from 2001 to 2004. Dentzer holds an honorary master’s degree from Dartmouth and an honorary doctorate in humane letters from Muskingum University. She and her husband, Charles Alston, have three adult children.

Agenda

7:00 AM – 7:55 AM Networking Breakfast

Note: our meeting will start promptly at 8:00 am so please plan to be in your seat by that time.

7:15 AM – 7:45 AM Pre-Conference Session: NLCRT Orientation           

New to either the NLCRT or the annual meeting? Come join the NLCRT Chair, Ella Kazerooni, MD, MS, NLCRT Vice Chair Douglas Wood, MD, NLCRT PI, Robert Smith, PhD, and NLCRT Director, Lauren Rosenthal, MPH, as they give an overview of the NLCRT. What we do and how we do it, in hopes of helping attendees get the most out of their involvement with the Roundtable.

 

8:00 AM – 8:15 AM

 

 

 

 

 

Welcome and Highlights from the National Lung Cancer Roundtable  

Ella Kazerooni, MD, MS

Chair, National Lung Cancer Roundtable

Professor of Radiology

University of Michigan

8:15 AM – 8:45 AM

 

Patient Advocate Story

Nina Beaty

The EmPat Cancer Project  

8:45 AM – 10:00 AM

 

 

 

 

 

Keynote Presentation and Population Health Conversation with the Experts

Introduction by:

Laurie Fenton Ambrose

Co-founder and CEO

 GO2 Foundation for Lung Cancer

Keynote Presentation:

Susan Dentzer

Visiting Fellow

Robert J. Margolis Center for Health Policy

Duke University

Population Health Conversation with the Experts:

Gregory Kane, MD

Jane and Leonard Korman Professor of Pulmonary Medicine
Chair, Department of Medicine

Sidney Kimmel Cancer Center at Jefferson

Richard Wender, MD

Chief Cancer Control Officer   

American Cancer Society

Bryan Loy, MD, MBA

Corporate Medical Director   

Humana

Geraldine McGinty, MD, MBA

Chief Contracting and Strategy Officer

Assistant Professor of Clinical Radiology

Weill Cornell Medical College, Cornell University

Chair, American College of Radiology Board of Chancellors

10:00 AM – 10:25 AM Break, Poster Presentations, and Networking 
10:30 AM – 12:30 PM Plenary Panel: State of Lung Cancer Today

Moderators:

Gerard Silvestri, MD, MS

Hillenbrand Professor of Thoracic Oncology

Division of Pulmonary and Critical Care Medicine

Medical University of South Carolina

Patricia Rivera, MD

Professor of Medicine

Division of Pulmonary and Critical Care Medicine

University of North Carolina at Chapel Hill

Panelists:

 1)  Progress in Lung Cancer Rates

Ahmedin Jemal, DVM, PhD

Scientific VP, Surveillance and Health Services

American Cancer Society

 2)   Status of Lung Cancer Screening in the Community

 Angela Criswell, MA

Associate Director, Quality Screening and Program Initiatives

GO2 Foundation for Lung Cancer

 3)  Lung Cancer Screening Evidence Update

David Yankelevitz, MD

Professor, Diagnostic, Molecular & Interventional Radiology

Icahn School of Medicine, Mount Sinai

 4)   Tobacco-Related Disparities

Brenna VanFrank, MD, MSPH

Senior Medical Officer, Office on Smoking and Health

Centers for Disease Control and Prevention

 5)     Primary Care: Knowledge, Attitudes, and Practices

Thomas Houston, MD

Adjunct Professor, Department of Family Medicine

The Ohio State University

 6)     Big Picture: Who is Being Screened?

Gerard Silvestri, MD, MS

Hillenbrand Professor of Thoracic Oncology

Division of Pulmonary and Critical Care Medicine

Medical University of South Carolina

7)     Lung Cancer Diagnosis and Treatment Evidence Update

Edward Kim, MD

Chair, Department of Solid Tumor Oncology

Levine Cancer Institute

12:30 PM – 1:10 PM Buffet Lunch and Networking
 

1:15 PM – 3:15 PM

Plenary Panel: State-Based Empowerment

Moderators:

Timothy Mullett, MD, MBA

Professor, Cardiothoracic Surgery

Medical Director, Markey Cancer Center

University of Kentucky

Jessica Olson, PhD, MPH

Assistant Professor, Institute for Health and Equity

Medical College of Wisconsin

Panelists:

1) Centers for Disease Control and Prevention – Overview of the CDC

Comprehensive Cancer Control Program

Elizabeth Rohan, PhD, MSW

Division of Cancer Prevention and Control

Centers for Disease Control and Prevention

2) Colorado – Colorado Lung Cancer Task Force

James Fenton, MD

Associate Professor, Department of Medicine

National Jewish Health

3) Delaware – Delaware Statewide Lung Cancer Screening Program

Stephen Grubbs, MD

VP, Clinical Affairs

American Society of Clinical Oncology

4) Michigan – Lung Cancer Screening: An Emerging Cancer Control Issue  

Presents Opportunities for an Awareness Campaign in Rural Michigan

Steven Springer

Unit Manager, Comprehensive Cancer Control

MI Department of Health and Human Services

5) North Carolina – Breaking the Stigma: Lung Cancer Initiative Summit

Paige Humble, MBA

Executive Director

Lung Cancer Initiative of North Carolina

6) West Virginia – Health Centers Advancing Lung Cancer Early Detection

(HALE) Program

Shauna Shafer

Health Systems Manager

American Cancer Society

7) Wisconsin – Wisconsin Lung Cancer Initiative

Jessica Olson, PhD, MPH

Assistant Professor, Institute for Health and Equity

Medical College of Wisconsin

3:15 PM – 3:45 PM

 

Break, Poster Presentations, Networking, and Move to Pre-selected Workshop
4:00 PM – 5:30 PM

 

 

 

 

 

 

 

 

 

Expert Workshops: Current Challenges and NLCRT Initiatives

 Comprehensive Biomarker Testing Workshop                             

Moderator:

Farhood Farjah, MD, MPH

Associate Professor of Surgery, Division of Cardiothoracic Surgery

University of Washington

 Panelists:

1) Emerging Trends in Precision Medicine for Lung Cancer

 Anna Berry, MD

Swedish Medical Center

2) Tissue Acquisition and Biomarker Testing in the Community and Academic  Settings

Gerard Silvestri, MD, MS

Hillenbrand Professor of Thoracic Oncology

Division of Pulmonary and Critical Care Medicine

Medical University of South Carolina

3)  Overcoming Barriers to Biomarker Testing

 Bruce Johnson, MD

Professor of Medicine, Adult Oncology

Dana Farber Cancer Institute

 4) NLCRT Summit: Optimizing Lung Cancer Biomarkers in Practice

M. Patricia Rivera, MD

Professor of Medicine

Division of Pulmonary and Critical Care Medicine

University of North Carolina at Chapel Hill

 Addressing Disparities in Urban and Rural Areas Workshop          

Moderator:

 Brendon Stiles, MD

Associate Professor, Department of Cardiothoracic Surgery

Weill Cornell Medical School

 Panelists:

1) Lung Cancer Atlas

Liora Sahar, PhD, GISP

Scientific Director, Geospatial Research

American Cancer Society

2)  Lung Cancer Screening in Low-income Populations in Chicago

Mary Pasquinelli, DNP, MSN

Director, Lung Cancer Screening Program

University of Illinois at Chicago

 3) American Lung Association Medicaid Survey

Paul Billings

Senior Vice President, Advocacy

American Lung Association

4) Surgical Disparities

Elizabeth David, MD, MAS

Associate Professor, Department of Clinical Surgery

University of Southern California

Essentials and Outreach in Lung Cancer Screening Workshop       

Co-Moderators:

William Mayfield, MD

Chief Surgical Officer

WellStar Health System

James Mulshine, MD

 Acting Dean, Graduate College

Rush University

Panelists:

1) Essentials of an Effective Lung Cancer Screening Program

Andrea McKee, MD

Radiation Oncologist

Lahey/Beth Israel Lahey Health

 2) Role of the Nurse Navigator

Vickie Beckler, MBA, RN

Principal Implementation and Education Specialist

Medtronic

3) Lung Cancer and the Primary Care Provider

Celeste Worth, MCHES

Director, LuCa National Training Network

University of Louisville

4) Improving Lung Cancer Screening Awareness for Individuals with Serious Mental Illness

Efren Flores, MD

Thoracic Radiologist

Massachusetts General Hospital

5) American College of Radiology Lung Cancer Screening 2.0 Initiative

Debra Dyer, MD

Chair, Department of Radiology

National Jewish Health

 Integrating Tobacco Cessation Across the Lung Cancer Continuum Workshop

                                                                                                                     

Moderator:

Jamie Ostroff, PhD

Chief, Behavioral Sciences Service

Memorial Sloan Kettering Cancer Center

Panelists:

 1) Smoking Cessation at Lung Examination Update: The SCALE Collaboration

Stephanie Land, PhD

Program Director

Behavioral Research Program Tobacco Control Research Branch

National Cancer Institute

 

2) Tobacco Cessation and Cancer Survivorship

Graham Warren, MD, PhD

Professor, Department of Radiation Oncology

Medical University of South Carolina

 

3) TeleTobacco: Examining the Practicalities of Delivering Smoking Cessation Services via Telehealth

 Joelle Fathi, DNP, RN, ANP-BC, NCTTP

 Clinical Associate Professor    

 University of Washington

4) Tobacco Treatment – One Size Does Not Fit All and Recognizing When it Won’t

Clifford Douglas, JD

Vice President, Tobacco Control

American Cancer Society

 

5:30 PM – 6:45 PM

 

6:45 PM

Networking Reception                                                 

 

Dinner on your own

7:00 AM – 7:50 AM Networking Breakfast

 

 

8:00 AM – 8:15 AM

 

 

 

 

 

Welcome and Recap

Douglas Wood, MD

Vice Chair, National Lung Cancer Roundtable

The Henry N. Harkins Professor and Chair

Department of Surgery, University of Washington

8:15 AM – 9:45 AM Plenary Panel: Strategic Planning and Harnessing Technology to Impact Lung Cancer

Moderators:

Joelle Fathi, DNP, RN, ANP-BC, NCTTP

Clinical Associate Professor    

University of Washington

Carey Thomson, MD, MPH

Chief, Pulmonary and Critical Care Division

 Mount Auburn Hospital/Beth Israel Lahey Health

Associate Professor, Harvard Medical School

 

Panelists:

Business Modeling and Software Technology to Drive High-Impact Lung Cancer Care

Carey Thomson, MD, MPH

Chief, Pulmonary and Critical Care Division

Mount Auburn Hospital/Beth Israel Lahey Health

Associate Professor, Harvard Medical School

 

Quality Metrics in Lung Cancer Screening: Setting Practice Standards

Peter Mazzone, MD, MPH

Director, Lung Cancer Program

Cleveland Clinic

Reaching High Risk Populations: Mobile Lung Cancer Screening Unit

Mellisa Wheeler, BSW, MHA

Administrative Director, Disparities and Outreach

Levine Cancer Institute

Project ECHO: ACS Comprehensive Lung Cancer Patient Support Program

Dawn Wiatrek, PhD

Interim SVP, Patient & Caregiver Support

American Cancer Society

 

The Emerging Role Telehealth in Remote Lung Cancer Care

Scott Shofer, MD, PhD

Associate Professor of Medicine

Duke University Medical Center

 

Advancing Telehealth through Action and Advocacy

Joelle Fathi, DNP, RN, ANP-BC, NCTTP

Clinical Associate Professor    

 University of Washington

10:30 AM – 12:00 PM

 

 

Plenary Panel: Stigma in Lung Cancer Care

Moderators:

Jamie Studts, PhD

Professor, Department of Behavioral Science

University of Kentucky College of Medicine

 

Heidi Hamann, PhD

Associate Professor

 Department of Psychology

Department of Family and Community Medicine

University of Arizona

Panelists:

Implicit Bias in Lung Cancer Healthcare

Heidi Hamann, PhD

Associate Professor

Department of Psychology

Department of Family and Community Medicine

University of Arizona

 

National Stigma Survey Data

Jennifer King, PhD

Senior Director, Science & Research

GO2 Foundation for Lung Cancer

 

Patient Advocate Experience

James Pantelas

Survivor Advocate

GO2 Foundation for Lung Cancer

An Empathic Communication Skills Training Module to Reduce Lung Cancer Stigma in Patients with Lung Cancer

Jamie Ostroff, PhD

Chief, Behavioral Sciences Service

Memorial Sloan Kettering Cancer Center

 

NLCRT Summit: Addressing Stigma Across the Lung Cancer Control Continuum

Jamie Studts, PhD

Professor, Department of Behavioral Science

University of Kentucky College of Medicine

 

 

1:00 PM – 2:30 PM Is Personalized Medicine in Sight for People with Lung Cancer?

Guest Speaker:

Anna Berry, MD

Scientific Director of Personalized Medicine

Medical Director of Molecular Diagnostics

Swedish Cancer Institute

Panelists:

Patient Advocate Experience

Gina Hollenbeck, RN, BSN

President

ALK Positive

 

NCCN Non-Small Cell Lung Cancer Panel Perspective

Gregory Riely, MD, PhD

Vice Chair, Clinical Research

Department of Medicine

Memorial Sloan Kettering Cancer Center

 

CMS Perspective on Biomarkers for Lung Cancer

Joseph Chin, MD, MS

Deputy Direct, Coverage and Analysis Group

Centers for Medicare and Medicaid Services

 

2:30 PM Closing Thoughts

Ella Kazerooni, MD, MS

2018 NLCRT Annual Meeting

Date: December 10-11, 2018

Location: DoubleTree Hilton, Washington DC, Crystal City

Each year, the NLCRT membership, a nationwide coalition of over 80 professional and national societies, cancer centers, government agencies, research groups, advocacy and policy organizations, and corporate associates convenes to work together on our shared goal to create lung cancer survivors.

The 2018 NLCRT Annual Meeting will feature presentations by nationally known experts, thought-leaders, and decision-makers on lung cancer and will facilitate national lung cancer awareness, prevention, early detection, and optimal therapy through public education, provider education, health policy activities, and the collective engagement of member organizations.

We need your critical thinking, expertise, and participation to advance our shared efforts.

Not currently a member? Learn more about NLCRT membership.

Featured Speaker

Susan J. Curry, PhD

Chairperson, United States Preventive Services Task Force

Interim Executive Vice President and Provost
University Of Iowa

Susan J. Curry was appointed interim executive vice president and provost of the University of Iowa in April 2017.  Prior to her appointment, Dr. Curry was dean of the UI College of Public Health, where she holds rank of distinguished professor in the Department of Health Management and Policy.

Agenda

7:30 AM Registration
7:30 AM – 8:25 AM Networking Breakfast
8:00 AM – 8:25 AM Pre-Conference Session: NLCRT Orientation 

New to either the NLCRT or the annual meeting? Or maybe you attended last year and still don’t know what anyone does beyond your own task group? Then this session is for you. Come join the NLCRT Chair, Ella Kazerooni, MD, MS, NLCRT Vice Chair Douglas Wood, MD, NLCRT PI, Robert Smith, PHD, and NLCRT Director, Lauren Rosenthal, MPH, as they give an overview of the NLCRT. What we do and how we do it, in hopes of helping attendees get the most out of their involvement with the Roundtable.

8:30 AM – 8:45 AM Welcome

Ella Kazerooni, MD, MS
Chair, National Lung Cancer Roundtable
Chair and Professor, Radiology
University of Michigan

8:45 AM – 9:00 AM Patient Advocate Story

Thomas Boyle
Seattle, Washington

9:00 AM – 9:30AM Keynote Speaker

Susan J. Curry, PhD
Chairperson, United States Preventive Services Task Force
Interim Executive Vice President and Provost
University of Iowa

9:30AM – 10:00AM Plenary Speaker: Stigma and Nihilism in Lung Cancer

Heidi Hamann, PhD
Associate Professor, Psychology; Family and Community Medicine
University of Arizona

Presentations:
Lung Cancer Stigma in Primary Care_Heidi Hamann

10:00 AM – 10:25 AM Poster Presentations and Networking
10:30 AM – 12:00 PM Plenary Panel: Tobacco Treatment in the Context of Lung Cancer Screening

Moderators:

Jamie Ostroff, PhD
Chief, Behavioral Sciences Service
Memorial Sloan Kettering Cancer Center

Peter Shields, MD
Deputy Director
The Ohio State University James Comprehensive Cancer Center

Panelists:

Brenna VanFrank, MD, MPH – CDC’s Tips From Former Smokers Campaign
Senior Medical Officer, Office on Smoking and Health
Centers for Disease Control and Prevention

Cliff Douglas, JD – National Partnership on Behavioral Health and Tobacco Use
Vice President, Tobacco Control
American Cancer Society

Stephanie Land, PhD – NCI’s Smoking Cessation at Lung Examination (SCALE) Collaboration
Program Director and Statistician, Tobacco Control Research Branch
National Cancer Institute

Glen Morgan, PhD – NCI’s Cancer Center Cessation Initiative (C3I)
Program Director, Behavioral Research Program
National Cancer Institute

Presentations:
The National Partnership on Behavioral Health and Tobacco Use_Cliff Douglas
NCI’s Smoking Cessation at Lung Examination (SCALE) Collaboration_Stephanie Land
NCI Cancer Center Smoking Cessation Initiative (P30 Supplement)_Glen Morgan

 

12:00 PM – 12:55 PM Buffet Lunch and Networking
1:00 PM – 2:30 PM Plenary Panel: Lung Cancer Screening Implementation

Moderators:

Charles White, MD
Professor, Diagnostic Radiology and Nuclear Medicine
University of Maryland School of Medicine

Peter Mazzone, MD, MPH
Director, Lung Cancer Program, Respiratory Institute
Director, Lung Cancer Screening Program
Cleveland Clinic

Panelists:

Andrea McKee, MD – ALA/ATS Lung Cancer Screening Implementation Guide
Radiation Oncologist
Lahey Hospital and Medical Center

Jamie Studts, PhD – Kentucky LEADS Quality Improvement in Lung Cancer Screening (QUILCS)
Professor, Department of Behavioral Science
University of Kentucky College of Medicine

Angela Criswell, MA – LCA National Framework of Excellence in Lung Cancer Screening and Continuum of Care
Senior Manager of Medical Outreach
Lung Cancer Alliance

Drew Moghanaki, MD, MPH – VA-PALS
PI, VA Partnership to Increase Access to Lung Screening (VA-PALS)
Director of Clinical Radiation Oncology Research
Hunter Holmes McGuire Veterans Affairs Medical Center

Ella Kazerooni, MD, MS – ACR Lung Cancer Screening Registry Update
Interim Chair and Professor, Radiology
University of Michigan

Presentations:
LCA National Framework of Excellence in Lung Cancer Screening and Continuum of Care_Angela Criswell
VA Partnership to Increase Access to Lung Screening_Drew Moghanaki

2:30 PM – 2:55 PM Poster Presentations and Networking
3:00 PM – 4:55 PM Task Group Breakout Strategy Sessions

Provider Engagement and Outreach Task Group
Lung Cancer Screening Implementation Strategies Task Group
Tobacco Treatment in the Context of Lung Cancer Screening Task Group
Triage for Appropriate Treatment Task Group
Shared Decision-Making Task Group
Lung Cancer in Women Task Group
Advanced Imaging Task Group
Policy Action Task Group
Survivorship, Stigma, and Nihilism Task Group
State-Based Initiatives Task Group

5:00 PM – 5:30 PM Closing Thoughts and Discussion

Ella Kazerooni, MD, MS
Douglas Wood, MD
Heidi Hamann, PhD
Peter Mazzone, MD, MPH
Jamie Ostroff, PhD
Peter Shields, MD
Charles White, MD

5:30 PM – 7:00 PM Networking Reception
7:00 AM – 8:00 AM Networking Breakfast
8:05 AM – 8:15 AM Welcome and Recap

Douglas Wood, MD
Vice Chair, National Lung Cancer Roundtable
The Henry N. Harkins Professor and Chair
Department of Surgery
University of Washington

8:15 AM – 8:30 AM Patient Advocate Story

Gina Hollenbeck, RN, BSN
President, ALK Positive
Memphis, Tennessee

8:30 AM – 10:00 AM Plenary Panel: Primary Care in Lung Cancer Control

Moderators:

Thomas Houston, MD
Adjunct Professor, Department of Family Medicine
The Ohio State University College of Medicine

Bellinda Schoof, MHA
Division Director, Health of the Public and Science
American Academy of Family Physicians

Panelists:

Jan Eberth, PhD – Perceptions and Practices of LDCT Lung Cancer Screening
Associate Professor, Epidemiology and Biostatistics
University of South Carolina

Celeste Worth, MCHES – LuCa National Training Network
Tobacco Treatment Specialist, Kentucky Cancer Program
Director, LuCa National Training Network

Lisa Carter-Harris, PhD, APRN – Lung Cancer Stigma in Primary Care
Associate Attending Behavioral Scientist
Memorial Sloan Kettering Cancer Center

Robert Volk, PhD – Practical Strategies for Promoting Shared Decision-Making in Primary Care Settings
Professor and Director, Decision Support Lab
The University of Texas MD Anderson Cancer Center

Presentations:

Perceptions and Practices of LDCT Lung Cancer Screening _Jan Eberth
LuCa National Training Network_Celeste Worth
Lung Cancer Stigma in Primary Care_Lisa Carter-Harris

 

10:00 AM – 10:25 AM Poster Presentations and Networking
10:30 AM – 12:00 PM Plenary Panel: Appropriate Treatment for Lung Cancer

Moderators:

Gerard Silvestri, MD, MS
Hillenbrand Professor of Thoracic Oncology
Division of Pulmonary and Critical Care Medicine
Medical University of South Carolina

Douglas Wood, MD
The Henry N. Harkins Professor and Chair
Department of Surgery
University of Washington

Farhood Farjah, MD, MPH
Associate Professor of Surgery
Associate Medical Director, Surgical Outcomes Research Center (SORCE)
University of Washington

Panelists:

Upal Basu Roy, PhD, MPH – Patient Knowledge and Perspectives on Biomarker Testing
Director of Translational Research Program/Director of Patient FoRCe
LUNGevity Foundation

James Jett, MD – Physician Knowledge and Perspectives on Biomarker Testing
Professor of Medicine, Emeritus
National Jewish Health, Denver

Peter Mazzone, MD, MPH – Thoughts from the Advances in the Early Detection of Lung Cancer Meeting
Director, Lung Cancer Screening Program
Cleveland Clinic

Liora Sahar, PhD, GISP– GIS Update: A Visualization and Analysis for Lung Cancer Research
Research Director, Geospatial Research
American Cancer Society

William Travis, MD – Overdiagnosis of Lung Cancer
Director, Thoracic Pathology Training Program
Memorial Sloan Kettering Cancer Center

Presentations:
Patient Knowledge and Perspectives on Biomarker Testing_BasuRoy
Overdiagnosis of Lung Cancer_WilliamTravis

 

12:00 PM – 12:55 PM Buffet Lunch and Networking
1:00 PM – 2:30 PM Plenary Panel: Learning from Effective State-Based Initiatives

Moderator:

Timothy Mullett, MD, MBA
Professor of Surgery
University of Kentucky Markey Cancer Center

William Mayfield, MD
Chief Surgical Officer
WellStar Health System (GA)

Panelists:

Andrea McKee, MD – Massachusetts Learning Collaborative on Lung Cancer Screening
Radiation Oncologist
Lahey Hospital and Medical Center

Jennifer Redmond Knight, DrPH – Kentucky LEADS Collaborative
Assistant Professor, Department of Health Management & Policy
University of Kentucky

William Mayfield, MD – Georgia Lung Cancer Roundtable
Chief Surgical Officer
WellStar Health System (GA)

Shonta Chambers, MSW – West Virginia Lung Cancer Project
Executive Vice President, Health Equity and Community Engagement
Patient Advocate Foundation

Caleb Levell – NCCRT State-Based Roundtables
Program Manager
National Colorectal Cancer Roundtable

Presentations:

Massachusetts Learning Collaborative on Lung Cancer Screening_AndreaMcKee
The Kentucky LEADS Collaborative_JenniferRedmondKnight
Georgia Lung Cancer Roundtable_WilliamMayfield
West Virginia Lung Cancer Project_ShontaChambers
NCCRT State-Based Roundtables_CalebLevell

2:30 PM – 3:00 PM Noteworthy Literature from 2018

M. Patricia Rivera, MD
Professor of Medicine
University of North Carolina, Chapel Hill

Presentations:
Noteworthy Literature of 2018_PatriciaRivera

 

3:00 PM – 3:30 PM Closing Thoughts and Discussion

Ella Kazerooni, MD, MS
Douglas Wood, MD
Farhood Farjah, MD, MPH
Thomas Houston, MD
William Mayfield, MD
Timothy Mullett, MD, MBA
Patricia Rivera, MD
Bellinda Schoof, MHA
Gerard Silvestri, MD, MS

3:30 PM Adjourn

2017 NLCRT Annual Meeting

Date: December 11 – 12, 2017

Location: DoubleTree Hilton, Bethesda, MD

With the formal launch of the NLCRT in 2017, we held our inaugural meeting of the NLCRT members on December 11-12, 2017 in Bethesda, Maryland. Membership was composed of nearly 70 patient and policy advocacy organizations, government agencies, cancer centers, professional and medical societies, and corporate associates who engaged and energized NLCRT members to strive to reduce the incidence of and mortality from lung cancer. All aspects of the NLCRT and its membership were showcased through plenary and breakout sessions dedicated to lung cancer screening implementation, provide engagement and outreach, tobacco treatment in the context of lung cancer screening, shared decision-making, and access to optimal therapy.  

Featured Speakers

Ella Kazerooni

Ella Kazerooni, MD, MS
NLCRT Chair
University of Michigan

Dr. Douglas Wood SCCA - photo by Kris Krüg

Douglas Wood, MD
NLCRT Vice Chair
University of Washington

Christopher Draft

Chris Draft
Founder, President, and CEO
The Chris Draft Family Foundation

Agenda

8:00 AM – 10:00 AM Registration
10:00 AM – 10:15 AM  Welcome

Richard Wender, MD, Co-Chair, National Colorectal Cancer Roundtable Chief Cancer Control Officer, American Cancer Society

Presentations:
The National Lung Cancer Roundtable:Now Is Our Moment – Richard C. Wender, MD

10:15 AM 11:05 AM Introducing the National Lung Cancer Roundtable

Ella Kazerooni, MD, MS, Chair, National Lung Cancer Roundtable Professor, Radiology; Associate Chair, Clinical Affairs; Director, Cardiothoracic Radiology Division; Chair, Radiology’s Service Excellence Program; University of Michigan Douglas Wood, MD, Vice Chair, National Lung Cancer Roundtable Henry N. Harkins Professor and Chair, Department of Surgery, University of Washington

Presentations:
National Lung Cancer Roundtable – Ella A. Kazerooni, MD, MS, FACR, FSCBTMR
American Cancer Society National Lung Cancer Roundtable – Douglas E. Wood, MD, FACS, FRCSEd

11:05 AM – 11:30 AM  Roundtables: How and Why They Work

Robert Smith, PhD, Principal Investigator, National Lung Cancer Roundtable and Co-Chair, National Colorectal Cancer Roundtable Vice President, Cancer Screening, American Cancer Society

Presentations:
Roundtables: How and Why They Work – Robert A. Smith, PhD

11:30 AM – 12:00 PM  Keynote Address

Christopher Draft Founder, President & CEO The Chris Draft Family Foundation Team Draft

12:00 PM – 1:00 PM Buffet Lunch and Networking
1:00 PM – 3:40 PM

1:00 PM – 1:50 PM

Afternoon Plenary Session I

Plenary Sessions on the state of lung cancer control, current challenges and key, relevant recent literature, organized under Task Group themes. Each group will have time for presentations and Q&A.

Provider Engagement and Outreach Panel

  Moderators: Chair: Thomas Houston, MD, Adjunct Professor, Department of Family Medicine, The Ohio State University College of Medicine Vice Chair: Ella Kazerooni, MD, MS, Professor of Radiology, University of Michigan

Plenary Speakers:

Thomas J. Van Hoof, MD, EdD Associate Professor University of Connecticut School of Nursing Provider Engagement and Changes in Practice Behavior that Incorporates Evidence-Based Clinical Guidelines for Lung Cancer Screening Jamie L. Studts, PhD  Professor, Department of Behavioral Science University of Kentucky College of Medicine Kentucky LEADS Collaborative and its Efforts on the Ground to Implement Lung Cancer Screening Guidelines

Presentations:
Early Efforts to Engage Clinicians Regarding Lung Cancer Screening in Kentucky – Jamie L. Studts, PhD
Evidence and Theory in Support of Guideline Implementation – Thomas J. Van Hoof, MD, EdD

1:55 PM – 2:45 PM Lung Cancer Screening Implementation Strategies Panel


Moderators:

Chair: Charles White, MD, Chief, Thoracic Radiology, University of Maryland Vice Chair: Peter Mazzone, MD, MPH, Director, Lung Cancer Program, Respiratory Institute, and Director, Lung Cancer Screening Program, Cleveland Clinic

Plenary Speakers:

Christopher Lathan, MD, MS, MPH Assistant Professor of Medicine, Harvard Medical School Medical Director, Dana-Farber Cancer Institute at St. Elizabeth’s Medical Center Disparities and Challenges to Access from the Perspective of Lung Cancer Screening Implementation Jane Kim, MD, MPH Deputy Chief Consultant for Preventive Medicine Veterans Affairs National Center for Health Promotion and Disease Prevention Outcomes of the Veterans Health Administration Demonstration Project and the Implementation Challenges Faced Claudia Henschke, MD, PhD Clinical Professor, Radiology Director, Lung Screening Program Mount Sinai Medical Center Ensuring Access and Optimizing Implementation in the ELCAP Cohort Carey Thomson, MD, MPH Chief, Pulmonary and Critical Care Medicine Mt. Auburn Hospital American Lung Association/American Thoracic Society’s Lung Cancer Screening Implementation Guide and Toolkit

Presentations:
Lung Cancer Screening with Low Dose Computed Tomography in the Veterans Health Administration – Jane Kim, MD, MPH
Disparities and Challenges to Access from the Perspective of Lung Cancer Screening Implementation – Christopher Lathan MD MS MPH
ALA/ATS GUIDE AND WEB-BASED TOOLKIT FOR IMPLEMENTATION OF LUNG CANCER SCREENING – Carey Thomson, MD, MPH

2:50 PM – 3:40 PM Tobacco Cessation in the Context of Lung Cancer Screening Panel

Moderators:

  Chair: Jamie Ostroff, PhD, Chief, Behavioral Sciences Service and Vice Chair for Research,    

    Director, Tobacco Treatment Program, Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering

Vice Chair: Peter Shields, MD, Professor, College of Medicine, Deputy Director,Comprehensive Cancer Center of Excellence in Regulatory Tobacco Science, The Ohio State University

Plenary Speakers: Hasmeena Kathuria, MD  Assistant Professor of Medicine Boston University School of Medicine Overview of Smoking Cessation in the Context of Lung Cancer Screening Elyse Park, PhD, MPH Associate Professor of Psychiatry Harvard Medical School/Massachusetts General Hospital NLST Findings Regarding Quitting Motivation and Attitudes Among High-Risk Smokers Seeking Lung Cancer Screening Steven Zeliadt, PhD, MPH Research Associate Professor of Health Services University of Washington School of Public Health VHA Findings Regarding Quitting Motivation and Attitudes among High-Risk Smokers Seeking Lung Cancer Screening

Presentations:
Overview: Integrating Smoking Cessation with Lung Cancer Screening – Hasmeena Kathuria, MD
NLST Findings Regarding Quitting Motivation & Attitudes – Elyse R. Park, Ph.D., MPH
Lung cancer screening & cessation motivation among current smokers: Snapshot of Screening in VA – Steven B. Zeliadt, PhD MPH

3:40 PM – 4:00 PM Afternoon Break
4:00 PM – 5:45 PM Afternoon Plenary Session II
4:00 PM – 4:50 PM Triage for Appropriate Treatment Panel

Moderators: Chair:

Gerard Silvestri, MD, MS, George Sr. and Margaret Hillenbrand Endowed Professor of Thoracic Oncology, Division of Pulmonary, Critical Care and Sleep Medicine, Medical University of South Carolina Vice Chair: Douglas Wood, MD, Henry N. Harkins Professor and Chair, Department of Surgery, University of Washington

Plenary Speakers: 

Elizabeth David, MD Assistant Professor of Surgery UC Davis Medical Center Disparities in Referral and Access to Lung Cancer Treatment Gerard Silvestri, MD, MS Variation in Guideline-directed Diagnosis & Treatment of Lung Cancer

Presentations:
Disparities in Lung Cancer Treatment – Elizabeth A David MD, MAS FACS
National Lung Cancer Roundtable: Triage for Appropriate Treatment – Gerard A. Silvestri MD,MS

4:55 PM – 5:45 PM Shared Decision-Making Panel

Moderators:  

Chair: Robert Volk, PhD, Department of Health Services Research, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center  

Vice Chair: Peter Mazzone, MD, MPH, Director, Lung Cancer Program, Respiratory Institute, and Director, Lung Cancer Screening Program, Cleveland Clinic

Plenary Speakers: 

Robert Volk, PhD Overview of Shared Decision-Making Peter Mazzone, MD, MPH Incorporation of Shared Decision-Making into Cleveland Clinic’s Lung Cancer Screening Program Nichole Tanner, MD, MSCR  Associate Professor, Division of Pulmonary and Critical Care Medical University of South Carolina Delivery Methods of Shared Decision-Making in Lung Cancer Screening: The Potential for Outreach

Presentations:
Lung Cancer Screening Counseling and Shared Decision Making Visit – Peter Mazzone, MD, MPH
Delivery methods of shared decision making in LCS: the potential for outreach – Nichole T. Tanner, MD, MSCR
Overview of Shared Decision Making – Robert J. Volk, PhD

5:45 PM – 7:00 PM Reception Hosted by AstraZeneca
7:00 PM Dinner on your own
7:30 AM – 8:30 AM Networking Breakfast
8:30 AM – 11:15 AM Task Group Breakout Session Open House
Task Group Chairs, Vice Chairs, and participating members will discuss their goals for 2018, challenges/needs, and special projects in a collaborative format with NLCRT organization members.Meeting attendees are invited to participate in any and all Task Group Breakout Open House meetings.Lung Cancer Screening Implementation Strategies Task Group (Breakout Room A)
Provider Engagement & Outreach Task Group (Breakout Room B)
Shared Decision-Making Task Group (Breakout Room C)
Tobacco Cessation in the Context of Lung Cancer Screening Task Group (Breakout Room D)
Triage for Appropriate Treatment Task Group (Breakout Room E)
11:15 AM – 11:30 AM Break
11:30 AM – 12:30 PM Working Buffet Lunch
12:00 PM – 12:30 PM NLCRT Website Presentation by Ghost Note Agency
Brandon Ellis, CEO
12:30 PM – 3:00 PM Task Group Showcase
Each Task Group will share the product of the morning Open House breakout sessions with the NLCRT membership in a plenary session and report on challenges, needs, and goals for 2018.Provider Engagement and Outreach Task Group (12:30 – 1:00 PM)
Lung Cancer Screening Implementation Strategies Task Group (1:00 – 1:30 PM)
Tobacco Cessation in the Context of Lung Cancer Screening Task Group (1:30 – 2:00 PM)
Triage for Appropriate Treatment Task Group (2:00 – 2:30 PM)
Shared Decision-Making Task Group (2:30 – 3:00 PM)
3:00 PM – 3:15 PM Closing Thoughts
3:15 PM Adjourn